Vanadium Carbide Nanosheets with Broad-Spectrum Antioxidant Activity for Pulmonary Fibrosis Therapy
Quan Liu,Yaping Ren,Huimin Jia,Hao Yuan,Yuping Tong,Sumasri Kotha,Xiaobo Mao,Yongwei Huang,Chunying Chen,Zhi Zheng,Liming Wang,Weiwei He
DOI: https://doi.org/10.1021/acsnano.3c06105
IF: 17.1
2023-11-07
ACS Nano
Abstract:Idiopathic pulmonary fibrosis is a chronic and highly lethal lung disease that largely results from oxidative stress; however, effective antioxidant therapy by targeting oxidative stress pathogenesis is still lacking. The big challenge is to develop an ideal antioxidant material with superior antifibrotic effects. Herein, we report that V<sub>4</sub>C<sub>3</sub> nanosheets (NSs) can serve as a potential antioxidant for treatment of pulmonary fibrosis by scavenging reactive oxygen and nitrogen species. Interestingly, subtle autoxidation can adjust the valence composition of V<sub>4</sub>C<sub>3</sub> NSs and significantly improve their antioxidant behavior. Valence engineering triggers multiple antioxidant mechanisms including electron transfer, H atom transfer, and enzyme-like catalysis, thus endowing V<sub>4</sub>C<sub>3</sub> NSs with broad-spectrum, high-efficiency, and persistent antioxidant capacity. Benefiting from antioxidant properties and good biocompatibility, V<sub>4</sub>C<sub>3</sub> NSs can significantly prevent myofibroblast proliferation and extracellular matrix abnormality, thus alleviating the progression of bleomycin-induced pulmonary fibrosis <i>in vivo</i> by scavenging ROS, anti-inflammation, and rebuilding antioxidant defenses. This study not only provides an important strategy for designing excellent antioxidant nanomaterials, but also proposes a proof-of-concept demonstration for the treatment of pulmonary fibrosis and other oxidative stress-related diseases.
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology